Skip Navigation

Ann Mullally, MD

Medical Oncology

Make an Appointment


  • Physician
  • Associate Professor of Medicine, Harvard Medical School

Clinical Interests

  • Hematopoietic stem cells (HSC)
  • Myeloid malignancies (primarily myeloproliferative neoplasms)
  • Myeloproliferative neoplasms

Contact Information

  • Appointments617-632-6140 (Hematologic Oncology)
    617-525-8337 (Non-Malignant Hematology)
  • Office Phone Number617-525-8337 (Non-Malignant Hematology)
  • Fax617-732-5706


Dr. Ann Mullally is a physician-scientist at Brigham and Women’s Hospital (BWH) / Dana-Farber Cancer Institute (DFCI). Her laboratory studies the genetics, biology and therapy of myeloproliferative neoplasms (MPN) using MPN patient samples, mouse models and multiple different laboratory approaches. Dr. Mullally’s MPN research interests include myelofibrosis, the biology of mutant calreticulin (CALR) in MPN, JAK2V617F MPN stem cells, improving the efficacy of JAK2 inhibitors and familial forms of MPN. The overarching goal of the research in her laboratory is to advance the understanding of the biology of MPN and to translate this into improved treatment options for patients dealing with these diseases.

Board Certification:

  • Hematology, 2009
  • Internal Medicine
  • Medical Oncology, 2010


  • Dana-Farber/Partners CancerCare, Hematology/Oncology


  • Johns Hopkins Hospital, Internal Medicine
  • Mayo Clinic, Internal Medicine

Medical School:

  • University College, Dublin


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions